4 research outputs found

    Pengaruh penambahan Aspergillus niger Iradiasi Sinar Gamma Dosis Rendah pada Jerami Padi Fermentasi dan Evaluasi Kualitasnya sebagai Pakan Ternak Ruminansia Secara In Vitro

    Get PDF
    Penelitian dilakukan untuk mengetahui pengaruh pemberian Aspergillus niger iradiasi sinar gamma dosis rendah pada jerami padi fermentasi dan potensinya sebagai pakan ternak ruminansia secara in vitro. Proses fermentasi dilakukan dengan teknik Solid State Fermentation (SSF) menggunakan A. niger yang diiradiasi sinar gamma dosis rendah untuk meningkatkan kemampuan memecah ikatan selulosa. Orientasi dosis iradiasi sinar gamma sebesar 0, 125, 250, 375, 500, 625 dan 750 Gy dilakukan pada A. niger untuk mengetahui kondisi yang optimum dalam menghasilkan aktivitas enzim selulase. A. niger iradiasi sinar gamma pada dosis yang optimum digunakan untuk pembuatan jerami padi fermentasi dan dilakukan evaluasi kemampuan jerami padi fermentasi sebagai pakan ternak ruminansia secara in vitro. Perlakuan jerami padi fermentasi yaitu P0. Jerami Padi, P1. Jerami padi fermentasi A. niger 0 Gy dan P2. Jerami padi fermentasi A. niger 500 Gy. Hasil menunjukkan bahwa dosis optimum iradiasi sinar gamma pada A. niger dalam menghasilkan enzim selulase (3,24 U/ml) adalah 500 Gy. Pada jerami padi fermentasi A. niger 500 Gy menunjukkan aktivitas enzim selulase tertinggi yaitu sebesar 48,5384 U/g bahan kering (BK) dan kadar glukosa sebesar 247,33 mg/g BK pada hari ke-14. Proses fermentasi dengan A. niger iradiasi sinar gamma (500 Gy) mampu meningkatkan kandungan proein kasar, acid detergent fiber (ADF), neutral detergent fiber (NDF) dan bahan kering, namun menurunkan kandungan lemak kasar dan bahan organik (BO). Hasil fermentasi dalam cairan rumen dari jerami padi fermentasi dengan dengan A. niger iradiasi sinar gamma (500 Gy) menunjukkan nilai pH sebesar 7,01; konsentrasi ammonia dan volatile fatty acid (VFA) masing-masing sebesar 3,92% dan 4,73 mmol/100

    Translocator Protein 18 kDa (TSPO): A Promising Molecular Target for Image-Guided Surgery of Solid Cancers

    No full text
    The translocator protein 18-kDa (TSPO) is a mitochondrial membrane protein that is previously identified as the peripheral benzodiazepine receptor (PBR). Furthermore, it plays a significant role in a diverse range of biochemical processes, including steroidogenesis, mitochondrial cholesterol transport, cell survival and death, cell proliferation, and carcinogenesis. Several investigations also reported its roles in various types of cancers, including colorectal, brain, breast, prostate, and lung cancers, as well as melanoma. According to a previous study, the expression of TSPO was upregulated in cancer cells, which corresponds to an aggressive phenotype and/or poor prognosis. Consequently, the potential for crafting diagnostic and prognostic tools with a focus on TSPO holds great potential. In this context, several radioligands designed to target this protein have been identified, and some of the candidates have advanced to clinical trials. In recent years, the use of hybrid probes with radioactive and fluorescence molecules for image-guided surgery has exhibited promising results in animal and human studies. This indicates that the approach can serve as a valuable surgical navigator during cancer surgery. The current hybrid probes are built from various molecular platforms, including small molecules, nanoparticles, and antibodies. Although several TSPO-targeted imaging probes have been developed, their development for image-guided surgery of cancers is still limited. Therefore, this review aims to highlight recent findings on the involvement of TSPO in carcinogenesis, as well as provide a new perspective on the potential application of TSPO-targeted hybrid probes for image-guided surgery

    Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2—A Candidate for Passive Immunization against COVID-19

    No full text
    The coronavirus disease 2019 (COVID-19) has become a substantial threat to the international health sector and the global economy. As of 26 December 2021, the number of mortalities resulting from COVID-19 exceeded 5.3 million worldwide. The absence of an effective non-vaccine treatment has prompted the quest for prophylactic agents that can be used to combat COVID-19. This study presents the feasibility of chicken egg yolk antibody (IgY) anti-receptor-binding domain (RBD) spike SARS-CoV-2 as a strong candidate to neutralize the virus for application in passive immunization. For the purpose of preclinical studies, we radiolabeled IgY anti-RBD spike SARS-CoV-2 with radionuclide iodine-131. This allowed us to evaluate several biological characteristics of IgY in vitro, in vivo, and ex vivo. The preclinical data suggest that IgY anti-RBD spike SARS-CoV-2 could specifically bind to the SARS-CoV-2 antigens; however, little uptake was observed in normal cells (MRC-5) (<2%). Furthermore, the ex vivo biodistribution study revealed that IgY predominantly accumulated in the trachea of normal mice compared to other organs. We also found that IgY possessed a good safety profile when used as an intranasal agent. Taken together, we propose that IgY anti-RBD spike SARS-CoV-2 has the potential for application in passive immunization against COVID-19

    Anticancer activity of Indonesian Melia azedarach L.: Phyto-chemistry, in vitro and in silico studies

    No full text
    This study describes the isolation of bioactive compounds and their in vitro anticancer activities from Melia azedarach L leaves from Karanglor, Karangan, Karanganom Klaten, Central Java-Indonesia. Isolated and characterised were the phenolics, kaempferol 7-O-rutinoside 1 and 4-methoxyresorcinol 3, The anticancer activity of the crude methanol extract of M. azedarach against a number cell lines (LNCaP, MDA-MB-231, and MCF-7) was found to be moderate; kaempferol derivatives were notable for their antiproliferative activities. Computational analysis, including molecular docking simulations and molecular dynamic studies, were used to investigate the feasibility of radiolabelled versions of 1 and 3 as theranostic agents targeting tyrosine kinase-type cell surface receptor HER2 in cancer - the iodinated derivatives 2 and 4, respectively, were used in this investigation as surrogates. The corresponding radioiodinated 2 and 4 were found to have high binding affinities of 10.1 and 5.7 kcal/mol, respectively, and have a good stability on the receptor
    corecore